<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-03-01" modified="2020-08-12" version="158">
<accession>Q96RL1</accession>
<accession>A8MSA1</accession>
<accession>B3KMZ1</accession>
<accession>B4E3N2</accession>
<accession>Q5XKQ1</accession>
<accession>Q7Z3W7</accession>
<accession>Q8N5B9</accession>
<accession>Q9BZR1</accession>
<accession>Q9BZR5</accession>
<accession>Q9UHX7</accession>
<name>UIMC1_HUMAN</name>
<protein>
<recommendedName>
<fullName>BRCA1-A complex subunit RAP80</fullName>
</recommendedName>
<alternativeName>
<fullName>Receptor-associated protein 80</fullName>
</alternativeName>
<alternativeName>
<fullName>Retinoid X receptor-interacting protein 110</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin interaction motif-containing protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">UIMC1</name>
<name type="synonym">RAP80</name>
<name type="synonym">RXRIP110</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="32379" last="32388">
<title>RAP80: a novel nuclear protein that interacts with the retinoid-related testis-associated receptor.</title>
<authorList>
<person name="Yan Z."/>
<person name="Kim Y.-S."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="12080054"/>
<dbReference type="DOI" id="10.1074/jbc.m203475200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION IN TRANSCRIPTIONAL REPRESSION</scope>
<scope>INTERACTION WITH NR6A1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1998-12" db="EMBL/GenBank/DDBJ databases">
<title>A novel gene expressed in the human hypothalamus.</title>
<authorList>
<person name="Peng Y."/>
<person name="Gu Y."/>
<person name="Gu J."/>
<person name="Huang Q."/>
<person name="Fu S."/>
<person name="Wu T."/>
<person name="Dong H."/>
<person name="Jin W."/>
<person name="Fu G."/>
<person name="Han Z."/>
<person name="Chen Z."/>
<person name="Wang Y."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Hypothalamus</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2000-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Xu X."/>
<person name="Yang Y."/>
<person name="Gao G."/>
<person name="Xiao H."/>
<person name="Chen Z."/>
<person name="Han Z."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Hypothalamus</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5)</scope>
<source>
<tissue>Teratocarcinoma</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Esophageal carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Ovary</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-46</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="362" first="132" last="138">
<title>RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.</title>
<authorList>
<person name="Yan J."/>
<person name="Yang X.-P."/>
<person name="Kim Y.-S."/>
<person name="Joo J.H."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="17698038"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.07.158"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>INTERACTION WITH UBE2I</scope>
<scope>MUTAGENESIS OF LYS-9; LYS-19; LYS-31; LYS-52 AND LYS-61</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="6647" last="6656">
<title>The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response.</title>
<authorList>
<person name="Yan J."/>
<person name="Kim Y.S."/>
<person name="Yang X.-P."/>
<person name="Li L.-P."/>
<person name="Liao G."/>
<person name="Xia F."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="17621610"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-0924"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ALA-88 AND ALA-113</scope>
<scope>PHOSPHORYLATION AT SER-205 AND SER-402</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="716" last="720">
<title>CCDC98 targets BRCA1 to DNA damage sites.</title>
<authorList>
<person name="Liu Z."/>
<person name="Wu J."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="17643121"/>
<dbReference type="DOI" id="10.1038/nsmb1279"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Nat. Struct. Mol. Biol." volume="14" first="710" last="715">
<title>CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response.</title>
<authorList>
<person name="Kim H."/>
<person name="Huang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="17643122"/>
<dbReference type="DOI" id="10.1038/nsmb1277"/>
</citation>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Nucleic Acids Res." volume="35" first="1673" last="1686">
<title>Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha.</title>
<authorList>
<person name="Yan J."/>
<person name="Kim Y.S."/>
<person name="Yang X.-P."/>
<person name="Albers M."/>
<person name="Koegl M."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="17311814"/>
<dbReference type="DOI" id="10.1093/nar/gkl1112"/>
</citation>
<scope>INTERACTION WITH ESR1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="20759" last="20763">
<title>Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage.</title>
<authorList>
<person name="Wang B."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="18077395"/>
<dbReference type="DOI" id="10.1073/pnas.0710061104"/>
</citation>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Science" volume="316" first="1194" last="1198">
<title>Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response.</title>
<authorList>
<person name="Wang B."/>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Zhang D."/>
<person name="Smogorzewska A."/>
<person name="Giyi S."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525340"/>
<dbReference type="DOI" id="10.1126/science.1139476"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-140; SER-402 AND SER-419</scope>
<scope>MUTAGENESIS OF ALA-88; SER-92; ALA-113 AND SER-117</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Science" volume="316" first="1198" last="1202">
<title>RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites.</title>
<authorList>
<person name="Sobhian B."/>
<person name="Shao G."/>
<person name="Lilli D.R."/>
<person name="Culhane A.C."/>
<person name="Moreau L.A."/>
<person name="Xia B."/>
<person name="Livingston D.M."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="17525341"/>
<dbReference type="DOI" id="10.1126/science.1139516"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>PHOSPHORYLATION AT SER-101</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Science" volume="316" first="1202" last="1205">
<title>Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.</title>
<authorList>
<person name="Kim H."/>
<person name="Chen J."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="17525342"/>
<dbReference type="DOI" id="10.1126/science.1139621"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>PHOSPHORYLATION AT SER-101</scope>
<scope>MUTAGENESIS OF ALA-88; SER-92; ALA-113 AND SER-117</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="4269" last="4276">
<title>RAP80 responds to DNA damage induced by both ionizing radiation and UV irradiation and is phosphorylated at Ser 205.</title>
<authorList>
<person name="Yan J."/>
<person name="Yang X.-P."/>
<person name="Kim Y.-S."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="18519686"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-07-5950"/>
</citation>
<scope>PHOSPHORYLATION AT SER-205</scope>
<scope>MUTAGENESIS OF SER-205</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-627; SER-653 AND SER-677</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="740" last="754">
<title>MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.</title>
<authorList>
<person name="Shao G."/>
<person name="Patterson-Fortin J."/>
<person name="Messick T.E."/>
<person name="Feng D."/>
<person name="Shanbhag N."/>
<person name="Wang Y."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="19261746"/>
<dbReference type="DOI" id="10.1101/gad.1739609"/>
</citation>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="729" last="739">
<title>NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.</title>
<authorList>
<person name="Wang B."/>
<person name="Hurov K."/>
<person name="Hofmann K."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="19261749"/>
<dbReference type="DOI" id="10.1101/gad.1770309"/>
</citation>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
<scope>UBIQUITIN-BINDING</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Genes Dev." volume="23" first="719" last="728">
<title>MERIT40 facilitates BRCA1 localization and DNA damage repair.</title>
<authorList>
<person name="Feng L."/>
<person name="Huang J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19261748"/>
<dbReference type="DOI" id="10.1101/gad.1770609"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE BRCA1-A COMPLEX</scope>
<scope>INTERACTION WITH ABRAXAS1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Mol. Cell" volume="33" first="775" last="783">
<title>Linkage-specific avidity defines the lysine 63-linked polyubiquitin-binding preference of rap80.</title>
<authorList>
<person name="Sims J.J."/>
<person name="Cohen R.E."/>
</authorList>
<dbReference type="PubMed" id="19328070"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.02.011"/>
</citation>
<scope>FUNCTION IN UBIQUITIN-BINDING</scope>
<scope>DOMAIN UIM-LINKER</scope>
<scope>MUTAGENESIS OF 97-ARG--GLU-103 AND SER-101</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="849" last="860">
<title>Histone ubiquitination associates with BRCA1-dependent DNA damage response.</title>
<authorList>
<person name="Wu J."/>
<person name="Huen M.S.Y."/>
<person name="Lu L.-Y."/>
<person name="Ye L."/>
<person name="Dou Y."/>
<person name="Ljungman M."/>
<person name="Chen J."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="19015238"/>
<dbReference type="DOI" id="10.1128/mcb.01302-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-508</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Proc. Natl. Acad. Sci. U.S.A." volume="106" first="3166" last="3171">
<title>The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks.</title>
<authorList>
<person name="Shao G."/>
<person name="Lilli D.R."/>
<person name="Patterson-Fortin J."/>
<person name="Coleman K.A."/>
<person name="Morrissey D.E."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="19202061"/>
<dbReference type="DOI" id="10.1073/pnas.0807485106"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-46 AND SER-677</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-677</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="Mol. Cell" volume="47" first="383" last="395">
<title>Tandem protein interaction modules organize the ubiquitin-dependent response to DNA double-strand breaks.</title>
<authorList>
<person name="Panier S."/>
<person name="Ichijima Y."/>
<person name="Fradet-Turcotte A."/>
<person name="Leung C.C."/>
<person name="Kaustov L."/>
<person name="Arrowsmith C.H."/>
<person name="Durocher D."/>
</authorList>
<dbReference type="PubMed" id="22742833"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.05.045"/>
</citation>
<scope>UBIQUITIN-BINDING</scope>
<scope>LR MOTIF</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="Cell Rep." volume="5" first="180" last="193">
<title>A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses.</title>
<authorList>
<person name="Zheng H."/>
<person name="Gupta V."/>
<person name="Patterson-Fortin J."/>
<person name="Bhattacharya S."/>
<person name="Katlinski K."/>
<person name="Wu J."/>
<person name="Varghese B."/>
<person name="Carbone C.J."/>
<person name="Aressy B."/>
<person name="Fuchs S.Y."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="24075985"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.08.025"/>
</citation>
<scope>IDENTIFICATION IN THE ARISC COMPLEX</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-29; SER-101; SER-140; SER-466; SER-627; SER-653 AND SER-677</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-20; LYS-31; LYS-382; LYS-544; LYS-562 AND LYS-607</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-20</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-607</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-20; LYS-31; LYS-75; LYS-90; LYS-188; LYS-245; LYS-382; LYS-387; LYS-428; LYS-544; LYS-559; LYS-587; LYS-607; LYS-635; LYS-642; LYS-696 AND LYS-697</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="submission" date="2010-06" db="PDB data bank">
<title>The solution structure of the K63-Ub2:tUIMs complex.</title>
<authorList>
<person name="Sekiyama N."/>
<person name="Jee J."/>
<person name="Isogai S."/>
<person name="Akagi K."/>
<person name="Huang T."/>
<person name="Ariyoshi M."/>
<person name="Tochio H."/>
<person name="Shirakawa M."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 79-124</scope>
<scope>FUNCTION IN UBIQUITIN BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="12852" last="12862">
<title>Molecular basis for impaired DNA damage response function associated with the RAP80 E81 defect.</title>
<authorList>
<person name="Anamika X."/>
<person name="Markin C.J."/>
<person name="Rout M.K."/>
<person name="Spyracopoulos L."/>
</authorList>
<dbReference type="PubMed" id="24627472"/>
<dbReference type="DOI" id="10.1074/jbc.m113.538280"/>
</citation>
<scope>STRUCTURE BY NMR OF 74-131</scope>
<scope>MUTAGENESIS OF GLU-81</scope>
<scope>FUNCTION IN UBIQUITIN BINDING</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Breast Cancer Res. Treat." volume="117" first="453" last="459">
<title>Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases.</title>
<authorList>
<person name="Novak D.J."/>
<person name="Sabbaghian N."/>
<person name="Maillet P."/>
<person name="Chappuis P.O."/>
<person name="Foulkes W.D."/>
<person name="Tischkowitz M."/>
</authorList>
<dbReference type="PubMed" id="18695986"/>
<dbReference type="DOI" id="10.1007/s10549-008-0134-y"/>
</citation>
<scope>VARIANTS TRP-15; THR-353; LEU-435 AND ARG-511</scope>
</reference>
<comment type="function">
<text evidence="17 19 20 21 22 23 29 30 32 34 35 36">Ubiquitin-binding protein (PubMed:24627472). Specifically recognizes and binds 'Lys-63'-linked ubiquitin (PubMed:19328070, Ref.37). Plays a central role in the BRCA1-A complex by specifically binding 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). The BRCA1-A complex also possesses deubiquitinase activity that specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX. Also weakly binds monoubiquitin but with much less affinity than 'Lys-63'-linked ubiquitin. May interact with monoubiquitinated histones H2A and H2B; the relevance of such results is however unclear in vivo. Does not bind Lys-48'-linked ubiquitin. May indirectly act as a transcriptional repressor by inhibiting the interaction of NR6A1 with the corepressor NCOR1.</text>
</comment>
<comment type="subunit">
<text evidence="14 17 18 20 21 23 24 25 26 31 32 33">Interacts with TSP57 (By similarity). Component of the ARISC complex, at least composed of UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1 (PubMed:24075985). Component of the BRCA1-A complex, at least composed of the BRCA1, BARD1, UIMC1/RAP80, ABRAXAS1, BRCC3/BRCC36, BABAM2 and BABAM1/NBA1. In the BRCA1-A complex, interacts directly with ABRAXAS1. Interacts with ESR1, NR6A1 and UBE2I.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-725300">
<id>Q96RL1</id>
</interactant>
<interactant intactId="EBI-1263451">
<id>Q6UWZ7</id>
<label>ABRAXAS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-725300">
<id>Q96RL1</id>
</interactant>
<interactant intactId="EBI-621372">
<id>P54132</id>
<label>BLM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-725300">
<id>Q96RL1</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-725300">
<id>Q96RL1</id>
</interactant>
<interactant intactId="EBI-740850">
<id>O14641</id>
<label>DVL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9640371">
<id>Q96RL1-1</id>
</interactant>
<interactant intactId="EBI-1263451">
<id>Q6UWZ7</id>
<label>ABRAXAS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9640371">
<id>Q96RL1-1</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9640371">
<id>Q96RL1-1</id>
</interactant>
<interactant intactId="EBI-750352">
<id>P46736</id>
<label>BRCC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17761788">
<id>Q96RL1-2</id>
</interactant>
<interactant intactId="EBI-746453">
<id>P54725</id>
<label>RAD23A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17 19 20 21 22 23">Nucleus</location>
</subcellularLocation>
<text>Localizes at sites of DNA damage at double-strand breaks (DSBs).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96RL1-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96RL1-2</id>
<name>2</name>
<sequence type="described" ref="VSP_012935"/>
</isoform>
<isoform>
<id>Q96RL1-3</id>
<name>3</name>
<name>XHRIP110</name>
<sequence type="described" ref="VSP_012932"/>
</isoform>
<isoform>
<id>Q96RL1-4</id>
<name>4</name>
<name>X2HRIP110</name>
<sequence type="described" ref="VSP_012933 VSP_012934"/>
</isoform>
<isoform>
<id>Q96RL1-5</id>
<name>5</name>
<sequence type="described" ref="VSP_037264 VSP_037265"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="17">Expressed in testis, ovary, thymus and heart. Expressed in germ cells of the testis.</text>
</comment>
<comment type="domain">
<text evidence="14 34 35 36">The tandem UIM domains form a continuous 60 Angstrom-long alpha-helix and mediate binding to 'Lys-63'-linked ubiquitins. UIM1 and UIM2 bind to the proximal and distal ubiquitin moieties and recognize an 'Ile-44'-centered hydrophobic patch. Since UIMs don't interact with the 'Lys-63' isopeptide bond the UIM-linker region between the 2 UIM domains determines the selectivity for 'Lys-63'-linkage, and its length is very important for specificity.</text>
</comment>
<comment type="domain">
<text evidence="34">The Abraxas-interacting region (AIR) mediates the interaction with ABRAXAS1.</text>
</comment>
<comment type="PTM">
<text evidence="25">Sumoylated.</text>
</comment>
<comment type="PTM">
<text evidence="19 20 21 22 27">Phosphorylated upon DNA damage by ATM or ATR.</text>
</comment>
<comment type="similarity">
<text evidence="41">Belongs to the RAP80 family.</text>
</comment>
<comment type="sequence caution" evidence="41">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="AAH06078" version="1"/>
</conflict>
<text>Truncated C-terminus.</text>
</comment>
<dbReference type="EMBL" id="AF349313">
<property type="protein sequence ID" value="AAK61871.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF113538">
<property type="protein sequence ID" value="AAF14875.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF284749">
<property type="protein sequence ID" value="AAG59851.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF284753">
<property type="protein sequence ID" value="AAG59855.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK023044">
<property type="protein sequence ID" value="BAG51153.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304794">
<property type="protein sequence ID" value="BAG65544.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX537376">
<property type="protein sequence ID" value="CAD97618.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC027318">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC006078">
<property type="protein sequence ID" value="AAH06078.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC032561">
<property type="protein sequence ID" value="AAH32561.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4408.1">
<molecule id="Q96RL1-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS83050.1">
<molecule id="Q96RL1-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186226.1">
<molecule id="Q96RL1-1"/>
<property type="nucleotide sequence ID" value="NM_001199297.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001186227.1">
<molecule id="Q96RL1-1"/>
<property type="nucleotide sequence ID" value="NM_001199298.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001304890.1">
<molecule id="Q96RL1-2"/>
<property type="nucleotide sequence ID" value="NM_001317961.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_057374.3">
<molecule id="Q96RL1-1"/>
<property type="nucleotide sequence ID" value="NM_016290.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005265987.1">
<molecule id="Q96RL1-1"/>
<property type="nucleotide sequence ID" value="XM_005265930.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005265993.1">
<molecule id="Q96RL1-4"/>
<property type="nucleotide sequence ID" value="XM_005265936.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006714934.1">
<molecule id="Q96RL1-1"/>
<property type="nucleotide sequence ID" value="XM_006714871.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016865063.1">
<molecule id="Q96RL1-3"/>
<property type="nucleotide sequence ID" value="XM_017009574.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016865067.1">
<molecule id="Q96RL1-4"/>
<property type="nucleotide sequence ID" value="XM_017009578.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016865068.1">
<molecule id="Q96RL1-4"/>
<property type="nucleotide sequence ID" value="XM_017009579.1"/>
</dbReference>
<dbReference type="PDB" id="2MKF">
<property type="method" value="NMR"/>
<property type="chains" value="A=74-131"/>
</dbReference>
<dbReference type="PDB" id="2MKG">
<property type="method" value="NMR"/>
<property type="chains" value="A=74-131"/>
</dbReference>
<dbReference type="PDB" id="2N9E">
<property type="method" value="NMR"/>
<property type="chains" value="A=37-49"/>
</dbReference>
<dbReference type="PDB" id="2RR9">
<property type="method" value="NMR"/>
<property type="chains" value="C=79-124"/>
</dbReference>
<dbReference type="PDBsum" id="2MKF"/>
<dbReference type="PDBsum" id="2MKG"/>
<dbReference type="PDBsum" id="2N9E"/>
<dbReference type="PDBsum" id="2RR9"/>
<dbReference type="SMR" id="Q96RL1"/>
<dbReference type="BioGRID" id="119697">
<property type="interactions" value="89"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4425">
<property type="entry name" value="BRCA1-A complex"/>
</dbReference>
<dbReference type="CORUM" id="Q96RL1"/>
<dbReference type="DIP" id="DIP-29936N"/>
<dbReference type="IntAct" id="Q96RL1">
<property type="interactions" value="55"/>
</dbReference>
<dbReference type="MINT" id="Q96RL1"/>
<dbReference type="STRING" id="9606.ENSP00000366434"/>
<dbReference type="iPTMnet" id="Q96RL1"/>
<dbReference type="MetOSite" id="Q96RL1"/>
<dbReference type="PhosphoSitePlus" id="Q96RL1"/>
<dbReference type="BioMuta" id="UIMC1"/>
<dbReference type="DMDM" id="60390957"/>
<dbReference type="EPD" id="Q96RL1"/>
<dbReference type="jPOST" id="Q96RL1"/>
<dbReference type="MassIVE" id="Q96RL1"/>
<dbReference type="MaxQB" id="Q96RL1"/>
<dbReference type="PaxDb" id="Q96RL1"/>
<dbReference type="PeptideAtlas" id="Q96RL1"/>
<dbReference type="PRIDE" id="Q96RL1"/>
<dbReference type="ProteomicsDB" id="77977">
<molecule id="Q96RL1-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77978">
<molecule id="Q96RL1-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77979">
<molecule id="Q96RL1-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77980">
<molecule id="Q96RL1-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77981">
<molecule id="Q96RL1-5"/>
</dbReference>
<dbReference type="Antibodypedia" id="29168">
<property type="antibodies" value="251 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="51720"/>
<dbReference type="Ensembl" id="ENST00000377227">
<molecule id="Q96RL1-1"/>
<property type="protein sequence ID" value="ENSP00000366434"/>
<property type="gene ID" value="ENSG00000087206"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000506128">
<molecule id="Q96RL1-2"/>
<property type="protein sequence ID" value="ENSP00000427480"/>
<property type="gene ID" value="ENSG00000087206"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000510698">
<molecule id="Q96RL1-4"/>
<property type="protein sequence ID" value="ENSP00000423717"/>
<property type="gene ID" value="ENSG00000087206"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000511320">
<molecule id="Q96RL1-1"/>
<property type="protein sequence ID" value="ENSP00000421926"/>
<property type="gene ID" value="ENSG00000087206"/>
</dbReference>
<dbReference type="GeneID" id="51720"/>
<dbReference type="KEGG" id="hsa:51720"/>
<dbReference type="UCSC" id="uc063kam.1">
<molecule id="Q96RL1-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="51720"/>
<dbReference type="DisGeNET" id="51720"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000087206.16"/>
<dbReference type="GeneCards" id="UIMC1"/>
<dbReference type="HGNC" id="HGNC:30298">
<property type="gene designation" value="UIMC1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000087206">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="609433">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96RL1"/>
<dbReference type="OpenTargets" id="ENSG00000087206"/>
<dbReference type="PharmGKB" id="PA162408624"/>
<dbReference type="eggNOG" id="ENOG502QQGN">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000007635"/>
<dbReference type="HOGENOM" id="CLU_023109_1_0_1"/>
<dbReference type="InParanoid" id="Q96RL1"/>
<dbReference type="KO" id="K20775"/>
<dbReference type="OMA" id="QYQRHVD"/>
<dbReference type="PhylomeDB" id="Q96RL1"/>
<dbReference type="TreeFam" id="TF336575"/>
<dbReference type="PathwayCommons" id="Q96RL1"/>
<dbReference type="Reactome" id="R-HSA-5689901">
<property type="pathway name" value="Metalloprotease DUBs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693571">
<property type="pathway name" value="Nonhomologous End-Joining (NHEJ)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693607">
<property type="pathway name" value="Processing of DNA double-strand break ends"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69473">
<property type="pathway name" value="G2/M DNA damage checkpoint"/>
</dbReference>
<dbReference type="SIGNOR" id="Q96RL1"/>
<dbReference type="BioGRID-ORCS" id="51720">
<property type="hits" value="9 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="UIMC1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q96RL1"/>
<dbReference type="GeneWiki" id="UIMC1"/>
<dbReference type="GenomeRNAi" id="51720"/>
<dbReference type="Pharos" id="Q96RL1">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96RL1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q96RL1">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000087206">
<property type="expression patterns" value="Expressed in testis and 218 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96RL1">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96RL1">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070531">
<property type="term" value="C:BRCA1-A complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070530">
<property type="term" value="F:K63-linked polyubiquitin modification-dependent protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006302">
<property type="term" value="P:double-strand break repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006303">
<property type="term" value="P:double-strand break repair via nonhomologous end joining"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070537">
<property type="term" value="P:histone H2A K63-linked deubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010212">
<property type="term" value="P:response to ionizing radiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072425">
<property type="term" value="P:signal transduction involved in G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR038868">
<property type="entry name" value="RAP80"/>
</dbReference>
<dbReference type="InterPro" id="IPR040714">
<property type="entry name" value="RAP80_UIM"/>
</dbReference>
<dbReference type="InterPro" id="IPR003903">
<property type="entry name" value="UIM_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15932">
<property type="entry name" value="PTHR15932"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18282">
<property type="entry name" value="RAP80_UIM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00726">
<property type="entry name" value="UIM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50330">
<property type="entry name" value="UIM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51908">
<property type="entry name" value="ZF_UBZ4"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="BRCA1-A complex subunit RAP80" id="PRO_0000097547">
<location>
<begin position="1"/>
<end position="719"/>
</location>
</feature>
<feature type="domain" description="UIM 1" evidence="15">
<location>
<begin position="80"/>
<end position="99"/>
</location>
</feature>
<feature type="domain" description="UIM 2" evidence="15">
<location>
<begin position="105"/>
<end position="124"/>
</location>
</feature>
<feature type="zinc finger region" description="UBZ4-type" evidence="16">
<location>
<begin position="502"/>
<end position="529"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for transcriptional repression">
<location>
<begin position="1"/>
<end position="101"/>
</location>
</feature>
<feature type="region of interest" description="UIM-linker">
<location>
<begin position="97"/>
<end position="103"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with NR6A1 N-terminus">
<location>
<begin position="100"/>
<end position="200"/>
</location>
</feature>
<feature type="region of interest" description="AIR">
<location>
<begin position="270"/>
<end position="400"/>
</location>
</feature>
<feature type="region of interest" description="Necessary for interaction with NR6A1 C-terminus">
<location>
<begin position="400"/>
<end position="500"/>
</location>
</feature>
<feature type="region of interest" description="Zinc-finger-like region">
<location>
<begin position="505"/>
<end position="582"/>
</location>
</feature>
<feature type="short sequence motif" description="LR motif">
<location>
<begin position="60"/>
<end position="78"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="81"/>
<end position="108"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="29"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 6">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="46"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 20 21">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 19">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22 27">
<location>
<position position="205"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="379"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19 22">
<location>
<position position="402"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="419"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="466"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="627"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="653"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 7 8">
<location>
<position position="677"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 11 12">
<location>
<position position="20"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 12">
<location>
<position position="31"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="75"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="90"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="188"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="245"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 12">
<location>
<position position="382"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="387"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="428"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 12">
<location>
<position position="544"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="559"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="562"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="587"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9 10 12">
<location>
<position position="607"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="635"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="642"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="696"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12">
<location>
<position position="697"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_012933" evidence="39 40">
<location>
<begin position="1"/>
<end position="370"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_012932" evidence="40">
<location>
<begin position="1"/>
<end position="78"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_037264" evidence="37">
<original>SCRPSDASATRSRPLATGPSSQSHQEKTTDSGL</original>
<variation>VNMPCCKSLWRLISYIFDFCGVVVALGTSCSHL</variation>
<location>
<begin position="120"/>
<end position="152"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_037265" evidence="37">
<location>
<begin position="153"/>
<end position="719"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_012935" evidence="38">
<location>
<begin position="234"/>
<end position="399"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_012934" evidence="39 40">
<original>SKTKDFQESSIKSLKEKLLLEEEPTTSHGQ</original>
<variation>MLPLPDLDLWPLDRLPSPIKRKPQTLGSLK</variation>
<location>
<begin position="371"/>
<end position="400"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism not associated with susceptibility to breast cancer; dbSNP:rs13167812." id="VAR_051469" evidence="28">
<original>R</original>
<variation>W</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism not associated with susceptibility to breast cancer; dbSNP:rs143282828." id="VAR_055328" evidence="28">
<original>M</original>
<variation>T</variation>
<location>
<position position="353"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism not associated with susceptibility to breast cancer; dbSNP:rs3733876." id="VAR_051470" evidence="28">
<original>P</original>
<variation>L</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism not associated with susceptibility to breast cancer; dbSNP:rs13360277." id="VAR_051471" evidence="28">
<original>C</original>
<variation>R</variation>
<location>
<position position="511"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10475633." id="VAR_051472">
<original>G</original>
<variation>E</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect symoylation; when associated with A-19; A-31; A-52 and A-61." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="9"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect symoylation; when associated with A-9; A-31; A-52 and A-61." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect symoylation; when associated with A-9; A-19; A-52 and A-61." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect symoylation; when associated with A-9; A-19; A-31 and A-61." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect symoylation; when associated with A-9; A-19; A-31 and A-52." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces ubiquitin binding via UIM 1." evidence="35">
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs localization to DNA damages sites; when associated with A-92; S-113 and A-117." evidence="19 21 22">
<original>A</original>
<variation>G</variation>
<variation>S</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs localization to DNA damages sites; when associated with S-88; S-113 and A-117." evidence="19 21">
<original>S</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs the selectivity for 'K-63'-linked ubiquitin." evidence="34">
<original>REVNSQE</original>
<variation>AA</variation>
<location>
<begin position="97"/>
<end position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases the selectivity for 'K-63'-linked ubiquitin." evidence="34">
<original>REVNSQE</original>
<variation>AAAAAAA</variation>
<location>
<begin position="97"/>
<end position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs the selectivity for 'K-63'-linked ubiquitin." evidence="34">
<original>REVNSQE</original>
<variation>AAAAAAAAA</variation>
<location>
<begin position="97"/>
<end position="103"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly impairs the selectivity for 'K-63'-linked ubiquitin." evidence="34">
<original>S</original>
<variation>A</variation>
<variation>E</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ubiquitin-binding and localization to DNA damages sites; when associated with S-88; A-92 and A-117." evidence="19 21 22">
<original>A</original>
<variation>G</variation>
<variation>S</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs ubiquitin-binding and localization to DNA damages sites; when associated with S-88; A-92 and S-113." evidence="19 21">
<original>S</original>
<variation>A</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation at this position." evidence="27">
<original>S</original>
<variation>G</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with histone monoubiquitinated H2B without affecting the interaction with H2A." evidence="29">
<original>C</original>
<variation>A</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAH06078." ref="7" evidence="41">
<original>E</original>
<variation>K</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG51153." ref="4" evidence="41">
<original>E</original>
<variation>G</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAG59851." ref="3" evidence="41">
<original>V</original>
<variation>C</variation>
<location>
<position position="247"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK61871." ref="1" evidence="41">
<original>E</original>
<variation>G</variation>
<location>
<position position="347"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK61871." ref="1" evidence="41">
<original>E</original>
<variation>G</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAG59855." ref="3" evidence="41">
<original>H</original>
<variation>R</variation>
<location>
<position position="634"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAG51153." ref="4" evidence="41">
<original>D</original>
<variation>N</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAG59855." ref="3" evidence="41">
<original>D</original>
<variation>V</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="84"/>
<end position="94"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="119"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2MKF"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N9E"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5PQK4"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5U5Q9"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00213"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01256"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12080054"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17311814"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17525340"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17525341"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17525342"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17621610"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643121"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17643122"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17698038"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18077395"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18519686"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18695986"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19015238"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19202061"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261746"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261748"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19261749"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19328070"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24627472"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source ref="37"/>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="40" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<sequence length="719" mass="79727" checksum="56B7699E42395861" modified="2005-03-01" version="2">MPRRKKKVKEVSESRNLEKKDVETTSSVSVKRKRRLEDAFIVISDSDGEEPKEENGLQKTKTKQSNRAKCLAKRKIAQMTEEEQFALALKMSEQEAREVNSQEEEEEELLRKAIAESLNSCRPSDASATRSRPLATGPSSQSHQEKTTDSGLTEGIWQLVPPSLFKGSHISQGNEAEEREEPWDHTEKTEEEPVSGSSGSWDQSSQPVFENVNVKSFDRCTGHSAEHTQCGKPQESTGRGSAFLKAVQGSGDTSRHCLPTLADAKGLQDTGGTVNYFWGIPFCPDGVDPNQYTKVILCQLEVYQKSLKMAQRQLLNKKGFGEPVLPRPPSLIQNECGQGEQASEKNECISEDMGDEDKEERQESRASDWHSKTKDFQESSIKSLKEKLLLEEEPTTSHGQSSQGIVEETSEEGNSVPASQSVAALTSKRSLVLMPESSAEEITVCPETQLSSSETFDLEREVSPGSRDILDGVRIIMADKEVGNKEDAEKEVAISTFSSSNQVSCPLCDQCFPPTKIERHAMYCNGLMEEDTVLTRRQKEAKTKSDSGTAAQTSLDIDKNEKCYLCKSLVPFREYQCHVDSCLQLAKADQGDGPEGSGRACSTVEGKWQQRLKNPKEKGHSEGRLLSFLEQSEHKTSDADIKSSETGAFRVPSPGMEEAGCSREMQSSFTRRDLNESPVKSFVSISEATDCLVDFKKQVTVQPGSRTRTKAGRGRRRKF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

